Postmenopausal Osteoporosis

被引:821
作者
Black, Dennis M. [1 ]
Rosen, Clifford J. [2 ]
机构
[1] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[2] Maine Med Ctr, Res Inst, Scarborough, ME USA
关键词
BONE-MINERAL DENSITY; ZOLEDRONIC ACID; FRACTURE RISK; ANTIRESORPTIVE THERAPY; VERTEBRAL FRACTURES; RANDOMIZED-TRIAL; WOMEN; ALENDRONATE; PREVENTION; HIP;
D O I
10.1056/NEJMcp1513724
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 73-year-old asymptomatic white woman with a history of a Colles fracture of the left radius 10 years earlier presents for evaluation. Dual-energy x-ray absorptiometry reveals a bone mineral density (BMD) T score of -2.8 in the lumbar spine and -2.5 in the total hip. How should this case be managed?This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.
引用
收藏
页码:254 / 262
页数:9
相关论文
共 54 条
[1]  
Adler RA, 2015, J BONE MINER RES
[2]   Trends in Fracture Incidence: A Population-Based Study Over 20 Years [J].
Amin, Shreyasee ;
Achenbach, Sara J. ;
Atkinson, Elizabeth J. ;
Khosla, Sundeep ;
Melton, L. Joseph, III .
JOURNAL OF BONE AND MINERAL RESEARCH, 2014, 29 (03) :581-589
[3]  
[Anonymous], 2000, NIH Consens Statement, V17, P1
[4]   Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy The FLEX Study [J].
Bauer, Douglas C. ;
Schwartz, Ann ;
Palermo, Lisa ;
Cauley, Jane ;
Hochberg, Marc ;
Santora, Art ;
Cummings, Steven R. ;
Black, Dennis M. .
JAMA INTERNAL MEDICINE, 2014, 174 (07) :1126-1134
[5]  
Bauer DC, 2013, NEW ENGL J MED, V369, P1537, DOI [10.1056/NEJMcp1210380, 10.1056/NEJMc1314100]
[6]   Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [J].
Black, Dennis M. ;
Delmas, Pierre D. ;
Eastell, Richard ;
Reid, Ian R. ;
Boonen, Steven ;
Cauley, Jane A. ;
Cosman, Felicia ;
Lakatos, Peter ;
Leung, Ping Chung ;
Man, Zulema ;
Mautalen, Carlos ;
Mesenbrink, Peter ;
Hu, Huilin ;
Caminis, John ;
Tong, Karen ;
Rosario-Jansen, Theresa ;
Krasnow, Joel ;
Hue, Trisha F. ;
Sellmeyer, Deborah ;
Eriksen, Erik Fink ;
Cummings, Steven R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18) :1809-1822
[7]   Continuing Bisphosphonate Treatment for Osteoporosis - For Whom and for How Long? [J].
Black, Dennis M. ;
Bauer, Douglas C. ;
Schwartz, Ann V. ;
Cummings, Steven R. ;
Rosen, Clifford J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (22) :2051-2053
[8]   The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT) [J].
Black, Dennis M. ;
Reid, Ian R. ;
Boonen, Steven ;
Bucci-Rechtweg, Christina ;
Cauley, Jane A. ;
Cosman, Felicia ;
Cummings, Steven R. ;
Hue, Trisha F. ;
Lippuner, Kurt ;
Lakatos, Peter ;
Leung, Ping Chung ;
Man, Zulema ;
Martinez, Ruvie Lou Maria ;
Tan, Monique ;
Ruzycky, Mary Ellen ;
Su, Guoqin ;
Eastell, Richard .
JOURNAL OF BONE AND MINERAL RESEARCH, 2012, 27 (02) :243-254
[9]   Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur [J].
Black, Dennis M. ;
Kelly, Michael P. ;
Genant, Harry K. ;
Palermo, Lisa ;
Eastell, Richard ;
Bucci-Rechtweg, Christina ;
Cauley, Jane ;
Leung, Ping Chung ;
Boonen, Steven ;
Santora, Arthur ;
de Papp, Anne ;
Bauer, Douglas C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (19) :1761-1771
[10]   Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial [J].
Black, Dennis M. ;
Schwartz, Ann V. ;
Ensrud, Kristine E. ;
Cauley, Jane A. ;
Levis, Silvina ;
Quandt, Sara A. ;
Satterfield, Suzanne ;
Wallace, Robert B. ;
Bauer, Douglas C. ;
Palermo, Lisa ;
Wehren, Lois E. ;
Lombardi, Antonio ;
Santora, Arthur C. ;
Cummings, Steven R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (24) :2927-2938